Prescriptions; 340B Nondiscrimination Act; definitions; discriminatory actions; reimbursement; manufacturer; distributor; enforcement; Attorney General; Insurance Commissioner; violations; federal preemption; effective date.
HB 2048, the "340B Nondiscrimination Act," prohibits health insurers, pharmacy benefits managers (PBMs), and third-party payors from discriminating against healthcare providers participating in the federal 340B drug discount program. It specifically bans lower reimbursement rates for 340B drugs, extra fees or administrative burdens for 340B entities, exclusion from provider networks based on 340B status, and requirements to disclose 340B-specific billing details. The law applies to all 340B entities - such as community health centers and hospitals participating in the federal program - and ensures they receive equal treatment in billing, reimbursement, and network access. Enforcement is handled by the Attorney General, with the Oklahoma Medicaid program excluded from these provisions.
Bill status
vetoed
4 of 5 stages cleared
Introduction
Feb 2025
Committee Review
May 2025
House Passage
Mar 2025
Senate Passage
May 2025
Vetoed
May 2025
Introduced Feb 3, 2025
Vetoed May 19, 2025
Maddy AI version diff · 4 comparisons
What changed between versions
Floor (House)
→
Floor (Senate)
·
4 edits
MODERATE
The bill was amended to transition from a House version to a Senate version, incorporating specific committee amendments. The most significant change is the addition of a comprehensive 'As used in this act' section that formally defines key terms like '340B drug,' '340B entity,' and 'Pharmacy benefits manager.' Additionally, the Senate version expanded the list of prohibited discriminatory actions by PBM payors to include specific restrictions on network participation, audit requirements, and claim processing modifiers.
Scope change
The scope of the bill's definitions was expanded to explicitly include 'affiliate pharmacies' of payors within the prohibited restrictions, and the list of prohibited actions was detailed with specific examples such as requiring billing modifiers or limiting network participation.
DEFINITION
Added a formal definitions section defining '340B drug,' '340B entity,' 'Pharmacy,' and 'Pharmacy benefits manager' to clarify the bill's application.
REQUIREMENT
Expanded prohibited actions for payors to include specific restrictions on network participation, inventory audit frequency, and requirements for billing modifiers or attestations.
Added a prohibition against including any contract provisions that discriminate against 340B entities or interfere with patient choice.
TECHNICAL
Updated header information and page footers to reflect the Senate Floor Version and include committee amendment notation.
Floor votes · Senate May 8, 2025 · House Mar 26, 2025
How they voted
42–5
Passed · 2 other
Total votes 49
May 8, 2025
D
Democratic9
100% Yea
R
Republican40
82% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
40
Key actions
12
Committee
8
Amendments
3
May 29, 2025
Introduced
Filed with Secretary of State
lower
May 29, 2025
Vetoed
Veto overridden: Ayes: 42 Nays: 3
upper
May 29, 2025
Vetoed
Veto overridden: Ayes: 79 Nays: 9
lower
May 19, 2025
Vetoed
Vetoed 05/17/2025
lower
May 8, 2025
Committee
Referred for enrollment
lower
May 8, 2025
Upper · Passed
Engrossed measure signed, returned to House
upper
May 8, 2025
Upper · Passed
Measure passed: Ayes: 40 Nays: 5
upper
May 8, 2025
Upper · Passed
Amendment restored bill to engrossed version
upper
May 8, 2025
Introduced
General Order, Amended
upper
Apr 23, 2025
Upper · Passed
Reported Do Pass Appropriations committee; CR filed
upper
Apr 14, 2025
Committee
Referred to Appropriations
upper
Apr 14, 2025
Upper · Passed
Reported Do Pass as amended Health and Human Services committee; CR filed
upper
Mar 27, 2025
Introduced
First Reading
upper
Mar 27, 2025
Lower · Passed
Engrossed, signed, to Senate
lower
Mar 26, 2025
Lower · Passed
Third Reading, Measure passed: Ayes: 83 Nays: 8
lower
Mar 26, 2025
Introduced
Amended by floor substitute
lower
Mar 26, 2025
Committee
Referred for engrossment
lower
Mar 26, 2025
Lower · Passed
Third Reading, Measure passed: Ayes: 82 Nays: 8
lower
Mar 6, 2025
Lower · Passed
CR; Do Pass Judiciary and Public Safety Oversight Committee
lower
Feb 20, 2025
Lower · Passed
Policy recommendation to the Judiciary and Public Safety Oversight committee; Do Pass Civil Judiciary
lower
Feb 4, 2025
Committee
Referred to Civil Judiciary
lower
Feb 3, 2025
Introduced
First Reading
lower
2 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 2048
Scope: OK
Hi! I can help you understand HB 2048. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline